Literature DB >> 29205903

Transduction Methods for Cytosolic Delivery of Proteins and Bioconjugates into Living Cells.

Manuela Chiper1,2, Karen Niederreither3,4, Guy Zuber1.   

Abstract

The human organism and its constituting cells rely on interplay between multiple proteins exerting specific functions. Progress in molecular biotechnologies has facilitated the production of recombinant proteins. When administrated to patients, recombinant proteins can provide important healthcare benefits. To date, most therapeutic proteins must act from the extracellular environment, with their targets being secreted modulators or extracellular receptors. This is because proteins cannot passively diffuse across the plasma membrane into the cytosol. To expand the scope of action of proteins for cytosolic targets (representing more than 40% of the genome) effective methods assisting protein cytosolic entry are being developed. To date, direct protein delivery is extremely tedious and inefficient in cultured cells, even more so in animal models of pathology. Novel techniques are changing this limitation, as recently developed in vitro methods can robustly convey large amount of proteins into cell cultures. Moreover, advances in protein formulation or protein conjugates are slowly, but surely demonstrating efficiency for targeted cytosolic entry of functional protein in vivo in tumor xenograft models. In this review, various methods and recently developed techniques for protein transport into cells are summarized. They are put into perspective to address the challenges encountered during delivery.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cytosolic delivery; intracellular delivery; protein carriers; protein transport; transduction

Mesh:

Substances:

Year:  2017        PMID: 29205903     DOI: 10.1002/adhm.201701040

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  9 in total

1.  Reversible Click Chemistry for Ultrafast and Quantitative Formation of Protein-Polymer Nanoassembly and Intracellular Protein Delivery.

Authors:  Bin Liu; Margareta Ianosi-Irimie; S Thayumanavan
Journal:  ACS Nano       Date:  2019-07-26       Impact factor: 15.881

Review 2.  Accessing Intracellular Targets through Nanocarrier-Mediated Cytosolic Protein Delivery.

Authors:  Ritabrita Goswami; Taewon Jeon; Harini Nagaraj; Shumei Zhai; Vincent M Rotello
Journal:  Trends Pharmacol Sci       Date:  2020-09-02       Impact factor: 14.819

Review 3.  Protein Delivery: If Your GFP (or Other Small Protein) Is in the Cytosol, It Will Also Be in the Nucleus.

Authors:  David C Luther; Taewon Jeon; Ritabrita Goswami; Harini Nagaraj; Dongkap Kim; Yi-Wei Lee; Vincent M Rotello
Journal:  Bioconjug Chem       Date:  2021-04-19       Impact factor: 4.774

4.  Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.

Authors:  Yongshuang Li; Hao Hou; Peng Zhang; Zhiyu Zhang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 5.  Protein Delivery into the Cell Cytosol using Non-Viral Nanocarriers.

Authors:  Yi-Wei Lee; David C Luther; Jessica A Kretzmann; Andrew Burden; Taewon Jeon; Shumei Zhai; Vincent M Rotello
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

Review 6.  Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.

Authors:  Song Zhang; Jiangtao Shen; Dali Li; Yiyun Cheng
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 7.  Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.

Authors:  Andrea L J Marschall
Journal:  BioDrugs       Date:  2021-10-27       Impact factor: 5.807

Review 8.  Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy.

Authors:  Zhihong Cheng; Yongshuang Li; Duoyi Zhao; Wei Zhao; Meng Wu; Weilin Zhang; Yan Cui; Peng Zhang; Zhiyu Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-06

Review 9.  mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles.

Authors:  Andreas Ouranidis; Theofanis Vavilis; Evdokia Mandala; Christina Davidopoulou; Eleni Stamoula; Catherine K Markopoulou; Anna Karagianni; Kyriakos Kachrimanis
Journal:  Biomedicines       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.